Javascript must be enabled to continue!
Hyperbaric Oxygen Treatment after Surgery and Radiation for Oral Cancers Does not Increase the Likelihood of a Second Primary Development, nor Reduce Disease Specific or Overall Survival
View through CrossRef
ABSTRACT
Hsieh CH, Wen YW, Liao CT, Lee SR. Hyperbaric Oxygen Treatment after Surgery and Radiation for Oral Cancers Does not Increase the Likelihood of a Second Primary Development, nor Reduce Disease Specific or Overall Survival. Undersea Hyperb Med. 2025 Third Quarter; 52(3):271-278.
Objective: This study aims to analyze whether receiving Hyperbaric oxygen (HBO2) therapy affects oral cancer prognosis using real-world data from the National Health Insurance Research Database (NHIRD) in Taiwan.
Method: This study is a retrospective cohort study. Cancer registration files, the NHIRD, and death statistics files from 2011 to 2019 were used for data extraction. We identified 6,297 oral cancer patients, all of whom underwent tumor resection surgery and radiation therapy. Among them, 254 patients received HBO2 therapy for osteoradionecrosis. We then divided them into two groups for comparison based on whether they received HBO2 therapy or not. First, propensity score matching was used to eliminate basic characteristic differences between the groups, and then Kaplan-Meier survival analysis was conducted. To eliminate immortal time bias and obtain hazard ratios, a time-dependent Cox proportional hazards model was used for estimation.
Result: After undergoing curative tumor resection combined with adjunctive radiation therapy, oral cancer patients were divided into two groups based on whether they received hyperbaric oxygen therapy. The estimation using a time-dependent Cox proportional hazards model showed no statistically significant differences in the three follow-up endpoints of this study: incidence of second primary cancer, disease-specific mortality, and all-cause mortality, in terms of hazard ratios.
Conclusion: In Taiwan, whether oral cancer patients receive hyperbaric oxygen therapy after curative tumor resection surgery combined with radiation therapy does not affect the incidence of second primary cancer, disease-specific mortality rate, and all-cause mortality rate.
Keywords: cancer registry; carcinogenesis and hyperbaric oxygen; survival after hyperbaric oxygen for oral cancers
Undersea and Hyperbaric Medical Society (UHMS)
Title: Hyperbaric Oxygen Treatment after Surgery and Radiation for Oral Cancers Does not Increase the Likelihood of a Second Primary Development, nor Reduce Disease Specific or Overall Survival
Description:
ABSTRACT
Hsieh CH, Wen YW, Liao CT, Lee SR.
Hyperbaric Oxygen Treatment after Surgery and Radiation for Oral Cancers Does not Increase the Likelihood of a Second Primary Development, nor Reduce Disease Specific or Overall Survival.
Undersea Hyperb Med.
2025 Third Quarter; 52(3):271-278.
Objective: This study aims to analyze whether receiving Hyperbaric oxygen (HBO2) therapy affects oral cancer prognosis using real-world data from the National Health Insurance Research Database (NHIRD) in Taiwan.
Method: This study is a retrospective cohort study.
Cancer registration files, the NHIRD, and death statistics files from 2011 to 2019 were used for data extraction.
We identified 6,297 oral cancer patients, all of whom underwent tumor resection surgery and radiation therapy.
Among them, 254 patients received HBO2 therapy for osteoradionecrosis.
We then divided them into two groups for comparison based on whether they received HBO2 therapy or not.
First, propensity score matching was used to eliminate basic characteristic differences between the groups, and then Kaplan-Meier survival analysis was conducted.
To eliminate immortal time bias and obtain hazard ratios, a time-dependent Cox proportional hazards model was used for estimation.
Result: After undergoing curative tumor resection combined with adjunctive radiation therapy, oral cancer patients were divided into two groups based on whether they received hyperbaric oxygen therapy.
The estimation using a time-dependent Cox proportional hazards model showed no statistically significant differences in the three follow-up endpoints of this study: incidence of second primary cancer, disease-specific mortality, and all-cause mortality, in terms of hazard ratios.
Conclusion: In Taiwan, whether oral cancer patients receive hyperbaric oxygen therapy after curative tumor resection surgery combined with radiation therapy does not affect the incidence of second primary cancer, disease-specific mortality rate, and all-cause mortality rate.
Keywords: cancer registry; carcinogenesis and hyperbaric oxygen; survival after hyperbaric oxygen for oral cancers.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens
Leder Macek AJ, Wang RS, Cottrell J, Kay-Rivest E, McMenomey SO, Roland Jr. T, Ross FL. Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens. Unders...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Hyperbaric medicine simulation education curriculum: CNS toxicity during Treatment Table 6 and intubated ICU patient with mucous plugging
Hyperbaric medicine simulation education curriculum: CNS toxicity during Treatment Table 6 and intubated ICU patient with mucous plugging
Introduction/Background: The incidence of complications and number of critically ill patients in hyperbaric medicine is relatively low [1]. This poses a challenge to those tasked w...
High Concentration Oxygen and Hypercapnia in Respiratory Disease
High Concentration Oxygen and Hypercapnia in Respiratory Disease
<p>Oxygen-induced elevations in arterial carbon dioxide tension have been demonstrated in patients with chronic obstructive pulmonary disease (COPD), asthma, pneumonia, obesi...

